(by Luke Yamaguchi | Children’s Health Defense) – The U.S. Food and Drug Administration (FDA) on Oct. 29, 2021, granted Emergency Use Authorization (EUA) of Pfizer’s COVID-19 vaccine for children 5 to 11 years of age.
ORIGINAL LINK
“Those who are able to see beyond the shadows and lies of their culture will never be understood, let alone believed, by the masses.” - Plato
Seeking Truth in a World of Propaganda. Links do not necessarily indicate agreement with stories or perspectives.
Friday, February 4, 2022
FDA used ‘critically flawed’ risk-benefit analysis to ‘justify’ COVID vaccines for children
(by Luke Yamaguchi | Children’s Health Defense) – The U.S. Food and Drug Administration (FDA) on Oct. 29, 2021, granted Emergency Use Authorization (EUA) of Pfizer’s COVID-19 vaccine for children 5 to 11 years of age.
ORIGINAL LINK